Aetna And Fresenius Medical Care North America Partner to Treat ESRD Patients

Aetna and FMC-NA are extending their value-based arrangement to better treat patients with ESRD—who are now eligible to enroll in Medicare Advantage (MA) plans. The partners will align reimbursement with quality benchmarks and develop metrics tied to CMS measures to better manage ESRD care.

Read the full article » | Posted 05-14-2021

Related Articles

• Outset Medical Beat Q2 Wall Street Projections Posted 09-14-2021
• Fresenius Invests to Help Humacyte Develop Implantable Blood Vessels Posted 09-14-2021
• Diality Appoints Chief Business Officer Posted 08-12-2021
• FMC-NA Names Joe Turk New President for Renal Therapies Group Posted 08-12-2021